Literature DB >> 5312191

Reversal of methotrexate toxicity in mice by 5-methyltetrahydrofolic acid.

J A Blair, C E Searle.   

Abstract

1. Mice have been compeletly protected against the lethal effects of repeated injections of methotrexate by 5-methyltetrahydrofolic acid. Methotrexate-resistant cells probably owe their resistance to their high content of this substance.2. Daily small doses were much more effective than fewer but larger doses.3. The reduced efficiency found in counteracting high dosages of methotrexate may be due to interference with folate transport across cell walls.4. 5-Methyltetrahydrofolic acid and citrovorum factor did not differ greatly in their ability to inhibit methotre toxicity. It is suggested that the pharmaceutical effects of citrovorum factor are due to its conversion to 5-methyltetrahydrofolic acid.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5312191      PMCID: PMC2008620          DOI: 10.1038/bjc.1970.73

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Studies on unbalanced growth in tissue culture. I. Induction and consequences of thymidine deficiency.

Authors:  R R RUECKERT; G C MUELLER
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Characteristics of folic acid transport in the L1210 leukemia cell.

Authors:  N S Lichtenstein; V T Oliverio; I D Goldman
Journal:  Biochim Biophys Acta       Date:  1969

3.  Cell killing studies on the mode of action of methotrexate on L-cells in vitro.

Authors:  J Borsa; G F Whitmore
Journal:  Cancer Res       Date:  1969-04       Impact factor: 12.701

4.  Transport energetics of the folic acid analogue, methotrexate, in L1210 leukemia cells. Enhanced accumulation by metabolic inhibitors.

Authors:  I D Goldman
Journal:  J Biol Chem       Date:  1969-07-25       Impact factor: 5.157

5.  [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].

Authors:  L Schwarzenberg; G Mathé; M Hayat; F de Vassal; J L Amiel; A Cattan; M Schneider; J R Schlumberger; C Rosenfeld; C Jasmin
Journal:  Presse Med       Date:  1969-03-01       Impact factor: 1.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.